Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 May;71(5):3742–3750. doi: 10.1128/jvi.71.5.3742-3750.1997

Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones.

Y Gaudin 1
PMCID: PMC191524  PMID: 9094649

Abstract

Four well-characterized monoclonal antibodies (MAbs) directed against rabies virus glycoprotein (G) were used to study G folding in vivo. Two of the MAbs were able to immunoprecipitate incompletely oxidized folding intermediates. The two others recognized G only after folding was completed. By using these MAbs, the ability of G to undergo low-pH-induced conformational changes during folding was also investigated. It appeared that some domains acquire this ability before folding is completed. In addition, interactions between unfolded G and some of the molecular chaperones were analyzed. Unfolded G was associated with BiP and calnexin. Association with BiP was maximal immediately after the pulse, whereas association with calnexin was maximal after 5 to 10 min of chase. The effects of tunicamycin and castanospermine on chaperone binding and folding were also studied. In the presence of both drugs, calnexin binding was reduced, consistent with the view that calnexin specifically recognizes monoglucosylated oligosaccharides, but some residual binding was still observed, indicating that calnexin also recognizes the polypeptide chain. In the presence of both drugs, association with BiP was increased and prolonged and folding was impaired. However, the global effects of the drugs were different, since folding was much more efficient in the presence of castanospermine than in the presence of tunicamycin. Taken together, these results provide the basis to draw a schematic view of rabies virus glycoprotein folding.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anilionis A., Wunner W. H., Curtis P. J. Structure of the glycoprotein gene in rabies virus. Nature. 1981 Nov 19;294(5838):275–278. doi: 10.1038/294275a0. [DOI] [PubMed] [Google Scholar]
  2. Benmansour A., Leblois H., Coulon P., Tuffereau C., Gaudin Y., Flamand A., Lafay F. Antigenicity of rabies virus glycoprotein. J Virol. 1991 Aug;65(8):4198–4203. doi: 10.1128/jvi.65.8.4198-4203.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braakman I., Hoover-Litty H., Wagner K. R., Helenius A. Folding of influenza hemagglutinin in the endoplasmic reticulum. J Cell Biol. 1991 Aug;114(3):401–411. doi: 10.1083/jcb.114.3.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cannon K. S., Hebert D. N., Helenius A. Glycan-dependent and -independent association of vesicular stomatitis virus G protein with calnexin. J Biol Chem. 1996 Jun 14;271(24):14280–14284. doi: 10.1074/jbc.271.24.14280. [DOI] [PubMed] [Google Scholar]
  5. Chen W., Helenius J., Braakman I., Helenius A. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6229–6233. doi: 10.1073/pnas.92.14.6229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coulon P., Rollin P. E., Flamand A. Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. J Gen Virol. 1983 Mar;64(Pt 3):693–696. doi: 10.1099/0022-1317-64-3-693. [DOI] [PubMed] [Google Scholar]
  7. Dietzschold B., Cox J. H., Schneider L. G. Rabies virus strains: a comparison study by polypeptide analysis of vaccine strains with different pathogenic patterns. Virology. 1979 Oct 15;98(1):63–75. doi: 10.1016/0042-6822(79)90525-7. [DOI] [PubMed] [Google Scholar]
  8. Dietzschold B. Oligosaccharides of the glycoprotein of rabies virus. J Virol. 1977 Aug;23(2):286–293. doi: 10.1128/jvi.23.2.286-293.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Doms R. W., Lamb R. A., Rose J. K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 1993 Apr;193(2):545–562. doi: 10.1006/viro.1993.1164. [DOI] [PubMed] [Google Scholar]
  10. Dunphy W. G., Rothman J. E. Compartmental organization of the Golgi stack. Cell. 1985 Aug;42(1):13–21. doi: 10.1016/s0092-8674(85)80097-0. [DOI] [PubMed] [Google Scholar]
  11. Gaudin Y., Raux H., Flamand A., Ruigrok R. W. Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein. J Virol. 1996 Nov;70(11):7371–7378. doi: 10.1128/jvi.70.11.7371-7378.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gaudin Y., Ruigrok R. W., Knossow M., Flamand A. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J Virol. 1993 Mar;67(3):1365–1372. doi: 10.1128/jvi.67.3.1365-1372.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gaudin Y., Ruigrok R. W., Tuffereau C., Knossow M., Flamand A. Rabies virus glycoprotein is a trimer. Virology. 1992 Apr;187(2):627–632. doi: 10.1016/0042-6822(92)90465-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gaudin Y., Tuffereau C., Durrer P., Flamand A., Ruigrok R. W. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation. J Virol. 1995 Sep;69(9):5528–5534. doi: 10.1128/jvi.69.9.5528-5534.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gaudin Y., Tuffereau C., Segretain D., Knossow M., Flamand A. Reversible conformational changes and fusion activity of rabies virus glycoprotein. J Virol. 1991 Sep;65(9):4853–4859. doi: 10.1128/jvi.65.9.4853-4859.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gething M. J., McCammon K., Sambrook J. Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell. 1986 Sep 12;46(6):939–950. doi: 10.1016/0092-8674(86)90076-0. [DOI] [PubMed] [Google Scholar]
  17. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  18. Hammond C., Braakman I., Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):913–917. doi: 10.1073/pnas.91.3.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hammond C., Helenius A. Folding of VSV G protein: sequential interaction with BiP and calnexin. Science. 1994 Oct 21;266(5184):456–458. doi: 10.1126/science.7939687. [DOI] [PubMed] [Google Scholar]
  20. Hammond C., Helenius A. Quality control in the secretory pathway. Curr Opin Cell Biol. 1995 Aug;7(4):523–529. doi: 10.1016/0955-0674(95)80009-3. [DOI] [PubMed] [Google Scholar]
  21. Hebert D. N., Foellmer B., Helenius A. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J. 1996 Jun 17;15(12):2961–2968. [PMC free article] [PubMed] [Google Scholar]
  22. Hebert D. N., Foellmer B., Helenius A. Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell. 1995 May 5;81(3):425–433. doi: 10.1016/0092-8674(95)90395-x. [DOI] [PubMed] [Google Scholar]
  23. Hurtley S. M., Bole D. G., Hoover-Litty H., Helenius A., Copeland C. S. Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP). J Cell Biol. 1989 Jun;108(6):2117–2126. doi: 10.1083/jcb.108.6.2117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jackson M. R., Cohen-Doyle M. F., Peterson P. A., Williams D. B. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science. 1994 Jan 21;263(5145):384–387. doi: 10.1126/science.8278813. [DOI] [PubMed] [Google Scholar]
  25. Kim P. S., Arvan P. Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum. J Cell Biol. 1995 Jan;128(1-2):29–38. doi: 10.1083/jcb.128.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631–664. doi: 10.1146/annurev.bi.54.070185.003215. [DOI] [PubMed] [Google Scholar]
  27. Lafay F., Benmansour A., Chebli K., Flamand A. Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. J Gen Virol. 1996 Feb;77(Pt 2):339–346. doi: 10.1099/0022-1317-77-2-339. [DOI] [PubMed] [Google Scholar]
  28. Lafay F., Coulon P., Astic L., Saucier D., Riche D., Holley A., Flamand A. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology. 1991 Jul;183(1):320–330. doi: 10.1016/0042-6822(91)90145-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lentz T. L., Wilson P. T., Hawrot E., Speicher D. W. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science. 1984 Nov 16;226(4676):847–848. doi: 10.1126/science.6494916. [DOI] [PubMed] [Google Scholar]
  30. Loo T. W., Clarke D. M. Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis. J Biol Chem. 1994 Nov 18;269(46):28683–28689. [PubMed] [Google Scholar]
  31. Machamer C. E., Doms R. W., Bole D. G., Helenius A., Rose J. K. Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. J Biol Chem. 1990 Apr 25;265(12):6879–6883. [PubMed] [Google Scholar]
  32. Margolese L., Waneck G. L., Suzuki C. K., Degen E., Flavell R. A., Williams D. B. Identification of the region on the class I histocompatibility molecule that interacts with the molecular chaperone, p88 (calnexin, IP90). J Biol Chem. 1993 Aug 25;268(24):17959–17966. [PubMed] [Google Scholar]
  33. Mathieu M. E., Grigera P. R., Helenius A., Wagner R. R. Folding, unfolding, and refolding of the vesicular stomatitis virus glycoprotein. Biochemistry. 1996 Apr 2;35(13):4084–4093. doi: 10.1021/bi952924i. [DOI] [PubMed] [Google Scholar]
  34. Mebatsion T., Schnell M. J., Conzelmann K. K. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J Virol. 1995 Mar;69(3):1444–1451. doi: 10.1128/jvi.69.3.1444-1451.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Melnick J., Dul J. L., Argon Y. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature. 1994 Aug 4;370(6488):373–375. doi: 10.1038/370373a0. [DOI] [PubMed] [Google Scholar]
  36. Mifune K., Ohuchi M., Mannen K. Hemolysis and cell fusion by rhabdoviruses. FEBS Lett. 1982 Jan 25;137(2):293–297. doi: 10.1016/0014-5793(82)80370-0. [DOI] [PubMed] [Google Scholar]
  37. Munro S., Pelham H. R. An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell. 1986 Jul 18;46(2):291–300. doi: 10.1016/0092-8674(86)90746-4. [DOI] [PubMed] [Google Scholar]
  38. Ora A., Helenius A. Calnexin fails to associate with substrate proteins in glucosidase-deficient cell lines. J Biol Chem. 1995 Nov 3;270(44):26060–26062. doi: 10.1074/jbc.270.44.26060. [DOI] [PubMed] [Google Scholar]
  39. Otteken A., Earl P. L., Moss B. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J Virol. 1996 Jun;70(6):3407–3415. doi: 10.1128/jvi.70.6.3407-3415.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ou W. J., Cameron P. H., Thomas D. Y., Bergeron J. J. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature. 1993 Aug 26;364(6440):771–776. doi: 10.1038/364771a0. [DOI] [PubMed] [Google Scholar]
  41. Prehaud C., Coulon P., LaFay F., Thiers C., Flamand A. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol. 1988 Jan;62(1):1–7. doi: 10.1128/jvi.62.1.1-7.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rajagopalan S., Xu Y., Brenner M. B. Retention of unassembled components of integral membrane proteins by calnexin. Science. 1994 Jan 21;263(5145):387–390. doi: 10.1126/science.8278814. [DOI] [PubMed] [Google Scholar]
  43. Raux H., Coulon P., Lafay F., Flamand A. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology. 1995 Jul 10;210(2):400–408. doi: 10.1006/viro.1995.1356. [DOI] [PubMed] [Google Scholar]
  44. Shakin-Eshleman S. H., Remaley A. T., Eshleman J. R., Wunner W. H., Spitalnik S. L. N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. J Biol Chem. 1992 May 25;267(15):10690–10698. [PubMed] [Google Scholar]
  45. Sousa M. C., Ferrero-Garcia M. A., Parodi A. J. Recognition of the oligosaccharide and protein moieties of glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. Biochemistry. 1992 Jan 14;31(1):97–105. doi: 10.1021/bi00116a015. [DOI] [PubMed] [Google Scholar]
  46. Sousa M., Parodi A. J. The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. EMBO J. 1995 Sep 1;14(17):4196–4203. doi: 10.1002/j.1460-2075.1995.tb00093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tatu U., Hammond C., Helenius A. Folding and oligomerization of influenza hemagglutinin in the ER and the intermediate compartment. EMBO J. 1995 Apr 3;14(7):1340–1348. doi: 10.1002/j.1460-2075.1995.tb07120.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tuffereau C., Leblois H., Bénéjean J., Coulon P., Lafay F., Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology. 1989 Sep;172(1):206–212. doi: 10.1016/0042-6822(89)90122-0. [DOI] [PubMed] [Google Scholar]
  49. Ware F. E., Vassilakos A., Peterson P. A., Jackson M. R., Lehrman M. A., Williams D. B. The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem. 1995 Mar 3;270(9):4697–4704. doi: 10.1074/jbc.270.9.4697. [DOI] [PubMed] [Google Scholar]
  50. Whitt M. A., Buonocore L., Prehaud C., Rose J. K. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology. 1991 Dec;185(2):681–688. doi: 10.1016/0042-6822(91)90539-n. [DOI] [PubMed] [Google Scholar]
  51. Wilson I. A., Skehel J. J., Wiley D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 1981 Jan 29;289(5796):366–373. doi: 10.1038/289366a0. [DOI] [PubMed] [Google Scholar]
  52. Wunner W. H., Dietzschold B., Smith C. L., Lafon M., Golub E. Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology. 1985 Jan 15;140(1):1–12. doi: 10.1016/0042-6822(85)90440-4. [DOI] [PubMed] [Google Scholar]
  53. Yelverton E., Norton S., Obijeski J. F., Goeddel D. V. Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli. Science. 1983 Feb 11;219(4585):614–620. doi: 10.1126/science.6297004. [DOI] [PubMed] [Google Scholar]
  54. Yewdell J. W., Yellen A., Bächi T. Monoclonal antibodies localize events in the folding, assembly, and intracellular transport of the influenza virus hemagglutinin glycoprotein. Cell. 1988 Mar 25;52(6):843–852. doi: 10.1016/0092-8674(88)90426-6. [DOI] [PubMed] [Google Scholar]
  55. van Leeuwen J. E., Kearse K. P. Calnexin associates exclusively with individual CD3 delta and T cell antigen receptor (TCR) alpha proteins containing incompletely trimmed glycans that are not assembled into multisubunit TCR complexes. J Biol Chem. 1996 Apr 19;271(16):9660–9665. doi: 10.1074/jbc.271.16.9660. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES